4.4 Article

Use patterns and self-reported effects of Salvia divinorum An Internet-based survey

Journal

DRUG AND ALCOHOL DEPENDENCE
Volume 111, Issue 3, Pages 250-256

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.drugalcdep.2010.05.003

Keywords

Salvia divinorum; Hallucinogen; Kappa opioid; Patterns of use; Subjective effects

Funding

  1. NIH [DA018179]
  2. Beckley Foundation

Ask authors/readers for more resources

Background There is growing use of Salvia divinorum (SD) a psychoactive plant that produces hallucinogen-like effects through a kappa opioid receptor (KOR) mechanism Little is known about KOR agonist effects in humans and about users of SD Objectives To characterize the reasons methods and reported consequences of SD use Methods Individuals reading SD-related pages of a drug-information website were invited to anonymously complete an online questionnaire if they had used SD Results Participants (N=500) were 92 6% male and 23 4 +/- 8 7 (mean +/- s d) years old They had used a median of six times (range 1-250) 80 6% probably or definitely would use SD again Most participants (92 6%) typically smoked or vaporized SD product When smoked the drug s main effects were estimated to last 14 1 +/- 12 8 (range 0 5-120) minutes When asked to compare SD effects to other methods of altering consciousness the most common answer was that SD was unique (38 4%) 25 8% reported persisting (>= 24 h) positive effects (often described as increased sense of well-being) on at least one occasion 4 4% reported persisting negative effects (most often anxiety) Conclusions SD is typically smoked acute effects are brief and persistent adverse effects are uncommon In addition to acute hallucinogenic effects SD may produce subacute increases in subjective well-being Such a subacute effect would be unusual for a drug that is used non-medically as withdrawal from other drugs typically either does not affect mood or causes dysphoria Findings from this convenience sample should be confirmed and extended using surveys of random samples and controlled clinical studies (C) 2010 Elsevier Ireland Ltd All rights reserved

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available